These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24433137)
21. "Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient? Kern MJ Catheter Cardiovasc Interv; 2012 Feb; 79(2):255-62. PubMed ID: 22271555 [No Abstract] [Full Text] [Related]
22. Aspirin, clopidogrel, and ticagrelor in acute coronary syndromes. Berger JS Am J Cardiol; 2013 Sep; 112(5):737-45. PubMed ID: 23751937 [TBL] [Abstract][Full Text] [Related]
24. Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor. Orban M; Riegger J; Joner M; Tada T; Okrojek R; Hausleiter J; Kastrati A; Massberg S; Sibbing D Platelets; 2012; 23(5):395-8. PubMed ID: 22671583 [TBL] [Abstract][Full Text] [Related]
25. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. Caiazzo G; De Rosa S; Torella D; Spaccarotella C; Mongiardo A; Giampà S; Micieli M; Palella E; Gulletta E; Indolfi C Circ Cardiovasc Interv; 2014 Feb; 7(1):104-12. PubMed ID: 24449597 [TBL] [Abstract][Full Text] [Related]
27. Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. Jeong YH; Bliden KP; Antonino MJ; Park KS; Tantry US; Gurbel PA Am Heart J; 2012 Jul; 164(1):35-42. PubMed ID: 22795280 [TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice. Bagai A; Chua D; Cohen EA; Saw J; Verma S; Vijayaraghavan R; Welsh R; Fitchett D Crit Pathw Cardiol; 2014 Dec; 13(4):156-8. PubMed ID: 25396293 [TBL] [Abstract][Full Text] [Related]
29. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Cannon CP; Harrington RA; James S; Ardissino D; Becker RC; Emanuelsson H; Husted S; Katus H; Keltai M; Khurmi NS; Kontny F; Lewis BS; Steg PG; Storey RF; Wojdyla D; Wallentin L; Lancet; 2010 Jan; 375(9711):283-93. PubMed ID: 20079528 [TBL] [Abstract][Full Text] [Related]
30. Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity. Lhermusier T; Voisin S; Murat G; Mejean S; Garcia C; Bataille V; Lipinski MJ; Carrié D; Sié P Int J Cardiol; 2014 Jul; 174(3):874-6. PubMed ID: 24820749 [No Abstract] [Full Text] [Related]
31. Clopidogrel-Associated Neutropenia: Case Report and Review of the Literature. Wu CW; Wu YJ; Wu CC Am J Ther; 2016; 23(5):e1197-201. PubMed ID: 25782570 [TBL] [Abstract][Full Text] [Related]
32. Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions. White HD Am Heart J; 2011 Mar; 161(3):450-61. PubMed ID: 21392598 [TBL] [Abstract][Full Text] [Related]
33. Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events. Myat A; Tantry US; Kubica J; Gurbel PA Expert Rev Cardiovasc Ther; 2016 Dec; 14(12):1361-1370. PubMed ID: 27740874 [TBL] [Abstract][Full Text] [Related]